StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Friday. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of AMPE opened at $0.00 on Friday. The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. The company has a market cap of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $1.99.
About Ampio Pharmaceuticals
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Myers Industries Poised for a Breakout?
- How to Calculate Return on Investment (ROI)
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
